Loss of α1,6-fucosyltransferase suppressed liver regeneration: Implication of core fucose in the regulation of growth factor receptor-mediated cellular signaling

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wang, Yuqin ^a   Fukuda, Tomohiko ^a   Isaji, Tomoya ^a   Lu, Jishun ^a   Gu, Wei ^a   Lee, Ho Hsun ^a   Ohkubo, Yasuhito ^a   Kamada, Yoshihiro ^b   Taniguchi, Naoyuki ^c   Miyoshi, Eiji ^b   Gu, Jianguo ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FUCOSE; FUCOSYLTRANSFERASE; GLYCOPROTEIN 6-ALPHA-L-FUCOSYLTRANSFERASE; GROWTH FACTOR RECEPTOR; SIGNAL PEPTIDE;

ANIMAL; ANIMAL MODEL; CELL PROLIFERATION; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; GENOTYPE; KNOCKOUT MOUSE; LIVER CELL; LIVER REGENERATION; LIVER RESECTION; METABOLISM; MOUSE; SIGNAL TRANSDUCTION;

ANIMALS; CELL PROLIFERATION; FUCOSE; FUCOSYLTRANSFERASES; GENE EXPRESSION; GENOTYPE; HEPATECTOMY; HEPATOCYTES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER REGENERATION; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; RECEPTORS, GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84954342228     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08264     Document Type: Article

References (38)

1. Taub, R. Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell Biol. 5, 836-847 (2004).
2. Michalopoulos, G. K. Liver regeneration. J. Cell Physil. 213, 286-300 (2007).
3. Michalopoulos, G. K. & DeFrances, M. Liver regeneration. Adv. Biochem. Eng. Biotechnol. 93, 101-134 (2005).
4. Michalopoulos, G. K. Advances in liver regeneration. Expert Rev. Gastroenterol. Hepatol. 8, 897-907 (2014).
5. Si-Tayeb, K., Lemaigre, F. P. & Duncan, S. A. Organogenesis and development of the liver. Dev. Cell 18, 175-189 (2010).
6. Fausto, N., Campbell, J. S. & Riehle, K. J. Liver regeneration. Hepatology 43, S45-53 (2006).
7. Boscher, C., Dennis, J. W. & Nabi, I. R. Glycosylation, galectins and cellular signaling. Curr. Opin. Cell Biol. 23, 383-392 (2011).
8. Snider, N. T. & Omary, M. B. Post-translational modifications of intermediate filament proteins: mechanisms and functions. Nat. Rev. Mol. Cell Biol. 15, 163-177 (2014).
9. Haltiwanger, R. S. & Lowe, J. B. Role of glycosylation in development. Annu. Rev. Biochem. 73, 491-537 (2004).
10. Wang, X. et al. Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proc. Natl. Acad. Sci. U S A 102, 15791-15796 (2005).
11. Wang, X. et al. Core fucosylation regulates epidermal growth factor receptormediated intracellular signaling. J. Biol. Chem. 281, 2572-2577 (2006).
12. Zhao, Y. et al. Deletion of core fucosylation on alpha3beta1 integrin downregulates its functions. J. Biol. Chem. 281, 38343-38350 (2006).
13. Gu, W. et al. alpha1,6-Fucosylation regulates neurite formation via the activin/phospho-Smad2 pathway in PC12 cells: the implicated dual effects of Fut8 for TGF-beta/activin-mediated signaling. FASEB J. 27, 3947-3958 (2013).
14. Hutchinson, W. L., Du, M. Q., Johnson, P. J. & Williams, R. Fucosyltransferases: differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis. Hepatology 13, 683-688 (1991).
15. Takahashi, T. et al. alpha1,6fucosyltransferase is highly and specifically expressed in human ovarian serous adenocarcinomas. Int. J. Cancer 88, 914-919 (2000).
16. Chen, C. Y. et al. Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer. Proc. Natl. Acad. Sci. U S A 110, 630-635 (2013).
17. Muinelo-Romay, L. et al. Expression and enzyme activity of alpha(1,6)fucosyltransferase in human colorectal cancer. Int. J. Cancer 123, 641-646 (2008).
18. Sano, K. et al. Survival signals of hepatic stellate cells in liver regeneration are regulated by glycosylation changes in rat vitronectin, especially decreased sialylation. J. Biol. Chem. 285, 17301-17309 (2010).
19. Yang, X., Tang, J., Rogler, C. E. & Stanley, P. Reduced hepatocyte proliferation is the basis of retarded liver tumor progression and liver regeneration in mice lacking N-acetylglucosaminyltransferase III. Cancer Res. 63, 7753-7759 (2003).
20. Becker, D. J. & Lowe, J. B. Fucose: biosynthesis and biological function in mammals. Glycobiology 13, 41R-53R (2003).
21. Hidalgo, A. et al. Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene. Blood 101, 1705-1712 (2003).
22. Borowiak, M. et al. Met provides essential signals for liver regeneration. Proc. Natl. Acad. Sci. U S A 101, 10608-10613 (2004).
23. Natarajan, A., Wagner, B. & Sibilia, M. The EGF receptor is required for efficient liver regeneration. Proc. Natl. Acad. Sci. U S A 104, 17081-17086 (2007).
24. Bohm, F., Kohler, U. A., Speicher, T.&Werner, S. Regulation of liver regeneration by growth factors and cytokines. EMBO Mol. Med. 2, 294-305 (2010).
25. Paranjpe, S. et al. Cell cycle effects resulting from inhibition of hepatocyte growth factor and its receptor c-Met in regenerating rat livers by RNA interference. Hepatology 45, 1471-1477 (2007).
26. Huh, C. G. et al. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc. Natl. Acad. Sci. U S A 101, 4477-4482 (2004).
27. Speicher, T. et al. Knockdown and knockout of beta1-integrin in hepatocytes impairs liver regeneration through inhibition of growth factor signalling. Nat. Commun. 5, 3862 (2014).
28. Ferrara, C. et al. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose. Proc. Natl. Acad. Sci. U S A 108, 12669-12674 (2011).
29. Mizushima, T. et al. Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans. Genes Cells 16, 1071-1080 (2011).
30. Okazaki, A. et al. Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa. J. Mol. Biol. 336, 1239-1249 (2004).
31. Shinkawa, T. et al. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J. Biol. Chem. 278, 3466-3473 (2003).
32. Jimenez-Romero, C. et al. Using old liver grafts for liver transplantation: Where are the limits? World J. Gastroenterol. 20, 10691-10702 (2014).
33. Fukuda, T. et al. Alpha1,6-fucosyltransferase-deficient mice exhibit multiple behavioral abnormalities associated with a schizophrenia-like phenotype: importance of the balance between the dopamine and serotonin systems. J. Biol. Chem. 286, 18434-18443 (2011).
34. Gao, L. et al. Reticulon 4B (Nogo-B) facilitates hepatocyte proliferation and liver regeneration in mice. Hepatology 57, 1992-2003 (2013).
35. Mitchell, C. &Willenbring, H. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat. Protoc. 3, 1167-1170 (2008).
36. Tokairin, T. et al. A highly specific isolation of rat sinusoidal endothelial cells by the immunomagnetic bead method using SE-1 monoclonal antibody. J. Hepatol. 36, 725-733 (2002).
37. Maher, J. J., Bissell, D. M., Friedman, S. L. & Roll, F. J. Collagen measured in primary cultures of normal rat hepatocytes derives from lipocytes within the monolayer. J. Clin. Invest. 82, 450-459 (1988).
38. Uozumi, N. et al. Purification and cDNA cloning of porcine brain GDP-L-Fuc:Nacetyl-beta-D-glucosaminide alpha1 - .6fucosyltransferase. J. Biol. Chem. 271, 27810-27817 (1996).